Literature DB >> 11156641

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis.

A J Wigg1, I C Roberts-Thomson, R B Dymock, P J McCarthy, R H Grose, A G Cummins.   

Abstract

BACKGROUND: Small intestinal bacterial overgrowth may contribute to the development of non-alcoholic steatohepatitis, perhaps by increasing intestinal permeability and promoting the absorption of endotoxin or other enteric bacterial products. AIMS: To investigate the prevalence of small intestinal bacterial overgrowth, increased intestinal permeability, elevated endotoxin, and tumour necrosis factor alpha (TNF-alpha) levels in patients with non-alcoholic steatohepatitis and in control subjects. PATIENTS AND METHODS: Twenty two patients with non-alcoholic steatohepatitis and 23 control subjects were studied. Small intestinal bacterial overgrowth was assessed by a combined (14)C-D-xylose and lactulose breath test. Intestinal permeability was assessed by a dual lactulose-rhamnose sugar test. Serum endotoxin levels were determined using the limulus amoebocyte lysate assay and TNF-alpha levels using an ELISA.
RESULTS: Small intestinal bacterial overgrowth was present in 50% of patients with non-alcoholic steatosis and 22% of control subjects (p=0.048). Mean TNF-alpha levels in non-alcoholic steatohepatitis patients and control subjects were 14.2 and 7.5 pg/ml, respectively (p=0.001). Intestinal permeability and serum endotoxin levels were similar in the two groups.
CONCLUSIONS: Patients with non-alcoholic steatohepatitis have a higher prevalence of small intestinal bacterial overgrowth, as assessed by the (14)C-D-xylose-lactulose breath test, and higher TNF-alpha levels in comparison with control subjects. This is not accompanied by increased intestinal permeability or elevated endotoxin levels.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11156641      PMCID: PMC1728215          DOI: 10.1136/gut.48.2.206

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  15 in total

1.  Detection of endotoxin in plasma and ascitic fluid of patients with cirrhosis: its clinical significance.

Authors:  K Tarao; K So; T Moroi; T Ikeuchi; T Suyama
Journal:  Gastroenterology       Date:  1977-09       Impact factor: 22.682

2.  Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin.

Authors:  A Ashkenazi; S A Marsters; D J Capon; S M Chamow; I S Figari; D Pennica; D V Goeddel; M A Palladino; D H Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

3.  Detection of small intestine bacterial overgrowth by means of a 14C-D-xylose breath test.

Authors:  C E King; P P Toskes; J C Spivey; E Lorenz; S Welkos
Journal:  Gastroenterology       Date:  1979-07       Impact factor: 22.682

4.  Non-alcoholic steatohepatitis associated with small intestinal diverticulosis and bacterial overgrowth.

Authors:  M Nazim; G Stamp; H J Hodgson
Journal:  Hepatogastroenterology       Date:  1989-10

5.  Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth.

Authors:  S N Lichtman; R B Sartor; J Keku; J H Schwab
Journal:  Gastroenterology       Date:  1990-02       Impact factor: 22.682

Review 6.  Abnormalities of liver function and hepatic damage associated with total parenteral nutrition.

Authors:  H R Freund
Journal:  Nutrition       Date:  1991 Jan-Feb       Impact factor: 4.008

7.  Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing.

Authors:  K M Mohler; P R Sleath; J N Fitzner; D P Cerretti; M Alderson; S S Kerwar; D S Torrance; C Otten-Evans; T Greenstreet; K Weerawarna
Journal:  Nature       Date:  1994-07-21       Impact factor: 49.962

8.  Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline.

Authors:  S N Lichtman; J Keku; J H Schwab; R B Sartor
Journal:  Gastroenterology       Date:  1991-02       Impact factor: 22.682

9.  Rapid and simultaneous quantification of rhamnose, mannitol, and lactulose in urine by HPLC for estimating intestinal permeability in pediatric practice.

Authors:  K Miki; R Butler; D Moore; G Davidson
Journal:  Clin Chem       Date:  1996-01       Impact factor: 8.327

10.  Polymyxin B reduces total parenteral nutrition-associated hepatic steatosis by its antibacterial activity and by blocking deleterious effects of lipopolysaccharide.

Authors:  I Pappo; H Bercovier; E M Berry; Y Haviv; R Gallily; H R Freund
Journal:  JPEN J Parenter Enteral Nutr       Date:  1992 Nov-Dec       Impact factor: 4.016

View more
  251 in total

Review 1.  Impact of liver diseases on the development of type 2 diabetes mellitus.

Authors:  Po-Shiuan Hsieh; Yen-Ju Hsieh
Journal:  World J Gastroenterol       Date:  2011-12-28       Impact factor: 5.742

Review 2.  What does irritable bowel syndrome share with non-alcoholic fatty liver disease?

Authors:  Antonella Scalera; Matteo Nicola Dario Di Minno; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

3.  Increased risk of NASH in patients carrying the C(-159)T polymorphism in the CD14 gene promoter region.

Authors:  P Brun; I Castagliuolo; A R Floreani; A Buda; L Blasone; G Palù; D Martines
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

4.  The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases.

Authors:  João-Bruno Soares; Pedro Pimentel-Nunes; Roberto Roncon-Albuquerque; Adelino Leite-Moreira
Journal:  Hepatol Int       Date:  2010-10-21       Impact factor: 6.047

5.  Precision-cut liver slices from diet-induced obese rats exposed to ethanol are susceptible to oxidative stress and increased fatty acid synthesis.

Authors:  Michael J Duryee; Monte S Willis; Courtney S Schaffert; Roger D Reidelberger; Anand Dusad; Daniel R Anderson; Lynell W Klassen; Geoffrey M Thiele
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-11-27       Impact factor: 4.052

Review 6.  Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis.

Authors:  Shivakumar Chitturi; Jacob George
Journal:  Curr Gastroenterol Rep       Date:  2003-02

Review 7.  Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis.

Authors:  Jacquelyn J Maher; Pablo Leon; James C Ryan
Journal:  Hepatology       Date:  2008-08       Impact factor: 17.425

8.  Risk factors and mechanisms of non-alcoholic steatohepatitis.

Authors:  Chantal A Rivera
Journal:  Pathophysiology       Date:  2008-07-29

Review 9.  Insulin resistance in development and progression of nonalcoholic fatty liver disease.

Authors:  Shahinul Alam; Golam Mustafa; Mahabubul Alam; Nooruddin Ahmad
Journal:  World J Gastrointest Pathophysiol       Date:  2016-05-15

10.  Effects of different diets on intestinal microbiota and nonalcoholic fatty liver disease development.

Authors:  Jian-Ping Liu; Wen-Li Zou; Shui-Jiao Chen; Hong-Yun Wei; Ya-Ni Yin; Yi-You Zou; Fang-Gen Lu
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.